| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/22/2001 | CA2382018A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | CA2381993A1 Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides |
| 02/22/2001 | CA2381979A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | CA2381409A1 Nitric ester derivatives |
| 02/22/2001 | CA2380991A1 Protective antigen of epstein barr virus |
| 02/22/2001 | CA2380817A1 Cell adhesion inhibitors |
| 02/22/2001 | CA2380753A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 02/22/2001 | CA2380653A1 Mycophenolate mofetil in association with peg-ifn-.alpha. |
| 02/22/2001 | CA2380642A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 02/22/2001 | CA2380635A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor |
| 02/22/2001 | CA2379196A1 Rotavirus vaccine formulations |
| 02/22/2001 | CA2379168A1 Chimeric dna/rna ribozymes containing propanediol |
| 02/22/2001 | CA2378332A1 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 02/22/2001 | CA2377646A1 Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 02/22/2001 | CA2377415A1 An oral administration form |
| 02/21/2001 | EP1077211A2 Process for the production of epigallocatechin gallate |
| 02/21/2001 | EP1077068A1 Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 02/21/2001 | EP1076718A1 Novel method for preparing synthesis intermediates |
| 02/21/2001 | EP1076691A1 Cellular and animal models for diseases associated with altered mitochondrial function |
| 02/21/2001 | EP1076662A2 Polyepitope carrier protein |
| 02/21/2001 | EP1076641A1 Inhibitors of impdh enzyme |
| 02/21/2001 | EP1076567A1 Compositions and method for immunizing poultry |
| 02/21/2001 | EP1076566A1 ATTENUATED MUTANTS OF $i(SALMONELLA) WHICH CONSTITUTIVELY EXPRESS THE Vi ANTIGEN |
| 02/21/2001 | EP1076565A1 Indolicidin analogs and methods of using same |
| 02/21/2001 | EP0784683B1 Tie-2 ligands, methods of making and uses thereof |
| 02/21/2001 | EP0734382B1 Crystalline n-acetyl neuraminic acid derivatives and processes for their preparation |
| 02/21/2001 | EP0725825B1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains |
| 02/21/2001 | EP0580635B2 Modified plant viruses as vectors |
| 02/21/2001 | EP0527852B2 Method and compositions for treating injury |
| 02/21/2001 | EP0526452B1 Hybrid immunoglobulins |
| 02/21/2001 | CN1285003A Screening appays for the detection and diagnosis of influenza virus |
| 02/21/2001 | CN1285001A Methods for simultaneous identification of novel biological targets and lead structures for drug development |
| 02/21/2001 | CN1284965A Novel surface protein of i (neisseria meningitidis) |
| 02/21/2001 | CN1284957A Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 02/21/2001 | CN1284945A Substituted pyriding and pyridazine compounds and their pharmaceutical use |
| 02/21/2001 | CN1284944A Integrin receptor antagonists |
| 02/21/2001 | CN1284943A Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 02/21/2001 | CN1284885A Vaccine |
| 02/21/2001 | CN1284884A 疫苗 Vaccine |
| 02/21/2001 | CN1284381A Recombined human interferon alpha gel preparation and its production process |
| 02/21/2001 | CN1284375A Tinea pedis treating method |
| 02/21/2001 | CN1284372A 'Sanhuangqinbao' powder-medicine for chicken |
| 02/21/2001 | CN1284369A Tinea pedis eliminating medicine |
| 02/21/2001 | CN1284334A Medicinal composition for treating AlDS |
| 02/21/2001 | CN1284332A Onychomycosis cream and its production process |
| 02/21/2001 | CN1284331A Application of 5,3',5'-trihydroxy-methoxyl dihydroflavone in preparing medicine |
| 02/21/2001 | CN1062171C Application of patchouli oil used as germicide for skin |
| 02/21/2001 | CN1062158C Ointment for treatment of skin superficial mycosis |
| 02/21/2001 | CN1062140C Method for extracting earthworm element from Japan Dula earthworm |
| 02/21/2001 | CN1062129C Medicine matrix and its use |
| 02/21/2001 | CN1062128C Ointment for eliminating tinea |
| 02/20/2001 | US6191271 Synthetic divalent sLex containing polylactosamines and methods for use |
| 02/20/2001 | US6191266 Sugar modified nucleosides |
| 02/20/2001 | US6191254 Of given amino acid sequences |
| 02/20/2001 | US6191172 Used in drugs and cosmetics |
| 02/20/2001 | US6191147 Pyrazole compounds and uses thereof |
| 02/20/2001 | US6191146 Hemoregulatory compounds |
| 02/20/2001 | US6191124 Methanol derivatives for treatment of retroviral infections especially HIV infections |
| 02/20/2001 | US6191120 Spermicidally active 5-halo-6-alkoxy-5,6-dihydro-2′,3′-dideoxy-uridines and their pharamaceutical compositions |
| 02/20/2001 | US6191114 Immunological activity for a peptide of the limulus anti-LPS factor |
| 02/20/2001 | US6191112 Human therapeutic uses of BPI protein products |
| 02/20/2001 | US6190901 Chicken interleukin-15 and uses thereof |
| 02/20/2001 | US6190891 Process for producing high-molecular-weight phenolic compounds with myrothecium |
| 02/20/2001 | US6190869 Antisense inhibition of protein kinase C-theta expression |
| 02/20/2001 | US6190866 Selecting bacterial target gene, preparing peptide nucleic acid having region complementary to target, identifying active peptide nucleic acid, contacting bacteria with active compounds, and determining effect on bacteria; bactericides |
| 02/20/2001 | US6190860 Method to detect CMV by hybridization with a gp55 specific DNA probe |
| 02/20/2001 | US6190859 Incubating sample with purified deactivated dengue virus having specific accession numbers, then detecting antibody-deactivated virus complex; safe diagnosis |
| 02/20/2001 | US6190685 Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 02/20/2001 | US6190669 Attenuated mutants of salmonella which constitutively express the Vi antigen |
| 02/20/2001 | US6190668 Providing cell mass of moraxella catarrhalis strain grown under iron-starved conditions to stimulate transferrin receptor protein expression; selectively extracting aqueous soluble proteins; separation; solubilizing; purification mass |
| 02/20/2001 | US6190667 Contacting parental helicobacter strain with molecule in biological sample and contacting helicobacter strain deficient in urei gene with molecule; comparing acidity sensitivity of both strains; selecting molecule that increases acidity |
| 02/20/2001 | US6190657 Vectors for the diagnosis and treatment of solid tumors including melanoma |
| 02/20/2001 | US6190656 Activating mammalian immune system entails series of il-2 administrations that are effected intermittently over an extended period; each administration of il-2 is sufficient to allow spontaneous dna synthesis; measuring dna synthesis |
| 02/20/2001 | US6190650 For prophylaxis and therapy of viral diseases in humans and animals |
| 02/20/2001 | US6190407 Medical article with adhered antimicrobial metal |
| 02/20/2001 | CA2223624C Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-.alpha.]pyridines |
| 02/20/2001 | CA2192289C Substituted heterocyclic derivatives |
| 02/20/2001 | CA2191789C Biaromatic compounds containing an adamantyl group in ortho position; pharmaceutical and cosmetic compositions containing them and use thereof |
| 02/20/2001 | CA1341181C Vaccines based on membrane bound proteins and process for making them |
| 02/15/2001 | WO2001011366A1 Antigenic components of selected indicator fungi and their use in methods and test kits |
| 02/15/2001 | WO2001011089A1 Novel method for screening compound for preventing or treating liver cell injury caused by hepatitis c virus and compound obtained by this method |
| 02/15/2001 | WO2001011067A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 02/15/2001 | WO2001011054A1 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STAPHYLOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB) |
| 02/15/2001 | WO2001011050A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 02/15/2001 | WO2001011046A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | WO2001011028A1 Glucuronoxylomannan (gxm)-o-acetylhydrolase of cryptococcus neoformans and uses thereof |
| 02/15/2001 | WO2001011027A1 New protein |
| 02/15/2001 | WO2001011024A2 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 02/15/2001 | WO2001011023A1 Treatment of inflammatory or malignant disease using dnazymes |
| 02/15/2001 | WO2001010912A1 Multiple cytokine-antibody complexes |
| 02/15/2001 | WO2001010906A1 Crystallization and structure determination of staphylococcus aureus elongation factor p |
| 02/15/2001 | WO2001010904A1 Map |
| 02/15/2001 | WO2001010901A2 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 02/15/2001 | WO2001010895A1 Streptogramin derivatives, production thereof and compositions containing the same |
| 02/15/2001 | WO2001010894A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/15/2001 | WO2001010893A2 Il-16 antagonists |
| 02/15/2001 | WO2001010880A1 Erythromycin a derivatives |
| 02/15/2001 | WO2001010879A1 Erythromycin a derivatives |
| 02/15/2001 | WO2001010878A1 Erythromycin a derivatives |
| 02/15/2001 | WO2001010865A1 p38MAP KINASE INHIBITORS |